Appendix 4E Preliminary Final Report

Name of entity

Admedus Limited

ABN Financial year ended ("current period")

35 088 221 078

30 June 2017

For announcement to the market $A'000's

Revenues from ordinary activities Up 57.8% to 22,324

Loss from ordinary activities after tax Down 49.6% to (12,676)

Loss for the year attributable to members Down 48.7% to (12,312)

Dividends

Amount per security

Franked amount per security

Final dividend proposed

NIL ¢

NIL ¢

Interim dividend

NIL¢

NIL¢

2017

2016

Net Tangible Asset Backing

6.9 cents

6.4 cents

Annual General Meeting

The Annual General Meeting will be held in Brisbane on the 16th of November 2017.

Audit

The financial statements on which this report is based have been audited.

ADMEDUS LIMITED ABN 35 088 221 078

ANNUAL FINANCIAL REPORT 30 JUNE 2017 CORPORATE DIRECTORY

Directors

Wayne Paterson ‐ CEO

John Seaberg ‐ Chairman

Mathew Ratty ‐ Non‐Executive Director

Simon Buckingham ‐ Non‐Executive Director (appointed 17/02/2017)

Michael Bennett ‐ Executive Director (resigned 17/02/2017)

Company Secretary

Maja McGuire

Company and Registered Office

26 Harris Road

Malaga, Western Australia 6090 Telephone: +61 8 9266 0100 Facsimile: +61 8 9266 0199 Website: www.admedus.com Email: info.au@admedus.com

Auditors

HLB Mann Judd Level 4, Stirling Street

Perth, Western Australia 6000

Solicitors

DLA Piper Australia

Level 31, 152‐158 St Georges Terrace Perth, Western Australia 6000

Bankers

ANZ

77 St Georges Terrace Perth, Western Australia 6000

Share Registry

Computershare Investor Services Pty Limited Level 11, 172 St Georges Terrace

Perth, Western Australia 6000

T: 1300 850 505 (within Australia

T: +61 3 9415 4000 (outside Australia) F: +61 3 9473 2500

Securities Exchange Listing

Australian Securities Exchange code: AHZ (ordinary shares)

CONTENTS

Directors' Report 1

Independence Declaration 18

Consolidated Statement of Profit or Loss 19

Consolidated Statement of Other Comprehensive Income 20

Consolidated Statement of Financial Position 21

Consolidated Statement of Changes in Equity 22

Consolidated Statement of Cash Flow 23

Notes to the Consolidated Financial Statements 24

Directors' Declaration 60

Independent Auditor's Report 61

Admedus Ltd. published this content on 31 August 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 30 August 2017 23:42:01 UTC.

Original documenthttp://clients2.weblink.com.au/clients/admedus/article.asp?asx=AHZ&view=6848917

Public permalinkhttp://www.publicnow.com/view/4F891AE59B2B25BCE527687A39B7BDCC35CA5EF3